These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25833456)

  • 21. The cardiovascular continuum in Asia--a new paradigm for the metabolic syndrome.
    Cheung BM
    J Cardiovasc Pharmacol; 2005 Aug; 46(2):125-9. PubMed ID: 16044022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Epidemiological study on cardiovascular and renal diseases in Okinawa].
    Takishita S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():126-30. PubMed ID: 16981532
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiometabolic risk management in type 2 diabetes and obesity.
    Taylor AM
    Curr Diab Rep; 2008 Oct; 8(5):345-52. PubMed ID: 18778582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiometabolic syndrome and chronic kidney disease.
    Lastra G; Manrique C; McFarlane SI; Sowers JR
    Curr Diab Rep; 2006 Jun; 6(3):207-12. PubMed ID: 16898573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of the metabolic syndrome: the impact of lifestyle modification.
    Pritchett AM; Foreyt JP; Mann DL
    Curr Atheroscler Rep; 2005 Mar; 7(2):95-102. PubMed ID: 15727723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiometabolic syndrome: pathophysiology and treatment.
    Castro JP; El-Atat FA; McFarlane SI; Aneja A; Sowers JR
    Curr Hypertens Rep; 2003 Oct; 5(5):393-401. PubMed ID: 12948432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic syndrome and heart failure--the risk, paradox, and treatment.
    Gaddam KK; Ventura HO; Lavie CJ
    Curr Hypertens Rep; 2011 Apr; 13(2):142-8. PubMed ID: 21298579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review.
    Wens I; Dalgas U; Stenager E; Eijnde BO
    Mult Scler; 2013 Oct; 19(12):1556-64. PubMed ID: 24048545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Operative risk factors in the metabolic syndrome: is it lipids and high blood pressure or are there direct vascular effects of insulin resistance and obesity?
    Ukkola O
    Curr Cardiol Rep; 2006 Nov; 8(6):427-32. PubMed ID: 17059794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age at adiposity rebound: determinants and association with nutritional status and the metabolic syndrome at adulthood.
    Péneau S; González-Carrascosa R; Gusto G; Goxe D; Lantieri O; Fezeu L; Hercberg S; Rolland-Cachera MF
    Int J Obes (Lond); 2016 Jul; 40(7):1150-6. PubMed ID: 27113489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child.
    l'Allemand-Jander D
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S32-6. PubMed ID: 21151144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The metabolic syndrome and inflammation: actual issues of pathogenesis].
    Sveklina TS; Talantseva MS; Barsukov AV
    Klin Lab Diagn; 2013 Mar; (3):7-10. PubMed ID: 23808015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypertension in obese children and adolescents].
    Peco-Antić A
    Srp Arh Celok Lek; 2009; 137(1-2):91-7. PubMed ID: 19370974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.
    McPherson KC; Shields CA; Poudel B; Fizer B; Pennington A; Szabo-Johnson A; Thompson WL; Cornelius DC; Williams JM
    Am J Physiol Renal Physiol; 2019 Feb; 316(2):F316-F327. PubMed ID: 30539649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-related differences in cardiometabolic risk factors and lifestyle behaviors in treatment-seeking adolescents with severe obesity.
    Barstad LH; Júlíusson PB; Johnson LK; Hertel JK; Lekhal S; Hjelmesæth J
    BMC Pediatr; 2018 Feb; 18(1):61. PubMed ID: 29444663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension.
    Landsberg L; Aronne LJ; Beilin LJ; Burke V; Igel LI; Lloyd-Jones D; Sowers J
    J Clin Hypertens (Greenwich); 2013 Jan; 15(1):14-33. PubMed ID: 23282121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of obesity on cardiovascular health.
    Chrostowska M; Szyndler A; Hoffmann M; Narkiewicz K
    Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):147-56. PubMed ID: 23731877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.